Drugs / DTP/Hib
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00314041 Background | Jun 1997 → Apr 1998 | meningococcal meningitis | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTP/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00314041 ↗ |
| Modality | Vaccine | “primary DTP/Hib vaccination” NCT00314041 ↗ |